 |
인쇄하기
취소
|
Teva, Handok to launch joint venture in September
A new joint venture between Israel-based Teva Pharmaceutical Industries and Handok Pharmaceutical is expected to commence activities in September, subject to receipt of applicable regulatory approvals after they created the business venture last February.
To this end, the joint venture appointed Hong Yoo-suk, a former CEO Lilly Korea, as its new president, Handok said Monday.
A graduate o...
To this end, the joint venture appointed Hong Yoo-suk, a former CEO Lilly Korea, as its new president, Handok said Monday.
A graduate o...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.